CLEARWATER ANALYTICS HDS-A (CWAN) Stock Fundamental Analysis

NYSE:CWAN • US1851231068

23.5 USD
-0.03 (-0.13%)
At close: Mar 3, 2026
23.5 USD
0 (0%)
After Hours: 3/3/2026, 7:05:42 PM
Fundamental Rating

4

Taking everything into account, CWAN scores 4 out of 10 in our fundamental rating. CWAN was compared to 276 industry peers in the Software industry. While CWAN seems to be doing ok healthwise, there are quite some concerns on its profitability. CWAN is valued quite expensively, but it does show have an excellent growth rating.


Dividend Valuation Growth Profitability Health

2

1. Profitability

1.1 Basic Checks

  • In the past year CWAN was profitable.
  • CWAN had a positive operating cash flow in the past year.
  • In the past 5 years CWAN reported 4 times negative net income.
  • In the past 5 years CWAN always reported a positive cash flow from operatings.
CWAN Yearly Net Income VS EBIT VS OCF VS FCFCWAN Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2019 2020 2021 2022 2023 2024 2025 0 200M -200M 400M

1.2 Ratios

  • Looking at the Return On Assets, with a value of -1.29%, CWAN is in line with its industry, outperforming 52.54% of the companies in the same industry.
  • CWAN has a Return On Equity (-1.93%) which is in line with its industry peers.
Industry RankSector Rank
ROA -1.29%
ROE -1.93%
ROIC N/A
ROA(3y)10.38%
ROA(5y)5.42%
ROE(3y)11.36%
ROE(5y)5.39%
ROIC(3y)N/A
ROIC(5y)N/A
CWAN Yearly ROA, ROE, ROICCWAN Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2019 2020 2021 2022 2023 2024 2025 0 20 -20 40 60

1.3 Margins

  • CWAN has a Gross Margin of 67.29%. This is comparable to the rest of the industry: CWAN outperforms 47.46% of its industry peers.
  • In the last couple of years the Gross Margin of CWAN has declined.
  • CWAN does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 67.29%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-1.8%
GM growth 5Y-1.83%
CWAN Yearly Profit, Operating, Gross MarginsCWAN Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2019 2020 2021 2022 2023 2024 2025 0 20 -20 40 60 80

4

2. Health

2.1 Basic Checks

  • CWAN does not have a ROIC to compare to the WACC, probably because it is not profitable.
  • Compared to 1 year ago, CWAN has more shares outstanding
  • The number of shares outstanding for CWAN has been increased compared to 5 years ago.
  • Compared to 1 year ago, CWAN has a worse debt to assets ratio.
CWAN Yearly Shares OutstandingCWAN Yearly Shares OutstandingYearly Shares Outstanding 2019 2020 2021 2022 2023 2024 2025 50M 100M 150M 200M 250M
CWAN Yearly Total Debt VS Total AssetsCWAN Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2019 2020 2021 2022 2023 2024 2025 1B 2B 3B

2.2 Solvency

  • An Altman-Z score of 4.50 indicates that CWAN is not in any danger for bankruptcy at the moment.
  • CWAN's Altman-Z score of 4.50 is fine compared to the rest of the industry. CWAN outperforms 75.00% of its industry peers.
  • CWAN has a debt to FCF ratio of 5.34. This is a neutral value as CWAN would need 5.34 years to pay back of all of its debts.
  • The Debt to FCF ratio of CWAN (5.34) is comparable to the rest of the industry.
  • CWAN has a Debt/Equity ratio of 0.40. This is a healthy value indicating a solid balance between debt and equity.
  • Looking at the Debt to Equity ratio, with a value of 0.40, CWAN is doing worse than 63.04% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 0.4
Debt/FCF 5.34
Altman-Z 4.5
ROIC/WACCN/A
WACC10.96%
CWAN Yearly LT Debt VS Equity VS FCFCWAN Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2019 2020 2021 2022 2023 2024 2025 0 500M 1B 1.5B 2B

2.3 Liquidity

  • CWAN has a Current Ratio of 1.83. This is a normal value and indicates that CWAN is financially healthy and should not expect problems in meeting its short term obligations.
  • CWAN has a Current ratio (1.83) which is comparable to the rest of the industry.
  • CWAN has a Quick Ratio of 1.83. This is a normal value and indicates that CWAN is financially healthy and should not expect problems in meeting its short term obligations.
  • With a Quick ratio value of 1.83, CWAN perfoms like the industry average, outperforming 54.71% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 1.83
Quick Ratio 1.83
CWAN Yearly Current Assets VS Current LiabilitesCWAN Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2019 2020 2021 2022 2023 2024 2025 100M 200M 300M 400M

9

3. Growth

3.1 Past

  • CWAN shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 20.00%, which is quite impressive.
  • The Earnings Per Share has been growing by 32.91% on average over the past years. This is a very strong growth
  • The Revenue has grown by 61.88% in the past year. This is a very strong growth!
  • The Revenue has been growing by 29.19% on average over the past years. This is a very strong growth!
EPS 1Y (TTM)20%
EPS 3Y32.91%
EPS 5YN/A
EPS Q2Q%15.38%
Revenue 1Y (TTM)61.88%
Revenue growth 3Y34.08%
Revenue growth 5Y29.19%
Sales Q2Q%71.95%

3.2 Future

  • CWAN is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 28.43% yearly.
  • CWAN is expected to show quite a strong growth in Revenue. In the coming years, the Revenue will grow by 18.78% yearly.
EPS Next Y31.28%
EPS Next 2Y29.98%
EPS Next 3Y33.51%
EPS Next 5Y28.43%
Revenue Next Year29.41%
Revenue Next 2Y23.63%
Revenue Next 3Y21.57%
Revenue Next 5Y18.78%

3.3 Evolution

  • The EPS growth rate is stable: in the next years the growth will be about the same than in the last years.
  • Although the future Revenue growth is still strong, it is not able to hold up the even more excellent growth rate of the past years.
CWAN Yearly Revenue VS EstimatesCWAN Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 2033 500M 1B 1.5B 2B 2.5B
CWAN Yearly EPS VS EstimatesCWAN Yearly EPS VS EstimatesYearly EPS VS Estimates 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 2033 1 2 3

3

4. Valuation

4.1 Price/Earnings Ratio

  • CWAN is valuated quite expensively with a Price/Earnings ratio of 43.52.
  • CWAN's Price/Earnings ratio is in line with the industry average.
  • CWAN's Price/Earnings ratio indicates a rather expensive valuation when compared to the S&P500 average which is at 26.83.
  • A Price/Forward Earnings ratio of 33.15 indicates a quite expensive valuation of CWAN.
  • CWAN's Price/Forward Earnings is on the same level as the industry average.
  • The average S&P500 Price/Forward Earnings ratio is at 24.95. CWAN is valued slightly more expensive when compared to this.
Industry RankSector Rank
PE 43.52
Fwd PE 33.15
CWAN Price Earnings VS Forward Price EarningsCWAN Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30 40

4.2 Price Multiples

  • CWAN's Enterprise Value to EBITDA is on the same level as the industry average.
  • CWAN's Price/Free Cash Flow is on the same level as the industry average.
Industry RankSector Rank
P/FCF 44.7
EV/EBITDA 97.99
CWAN Per share dataCWAN EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 2 4 6

4.3 Compensation for Growth

  • CWAN's PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a correct valuation of the company.
  • A more expensive valuation may be justified as CWAN's earnings are expected to grow with 33.51% in the coming years.
PEG (NY)1.39
PEG (5Y)N/A
EPS Next 2Y29.98%
EPS Next 3Y33.51%

0

5. Dividend

5.1 Amount

  • No dividends for CWAN!.
Industry RankSector Rank
Dividend Yield 0%

CLEARWATER ANALYTICS HDS-A

NYSE:CWAN (3/3/2026, 7:05:42 PM)

After market: 23.5 0 (0%)

23.5

-0.03 (-0.13%)

Chartmill FA Rating
GICS IndustryGroupSoftware & Services
GICS IndustrySoftware
Earnings (Last)02-18
Earnings (Next)04-29
Inst Owners99.01%
Inst Owner Change10.24%
Ins Owners0.84%
Ins Owner Change31.64%
Market Cap6.89B
Revenue(TTM)731.37M
Net Income(TTM)-39.12M
Analysts73.75
Price Target25.21 (7.28%)
Short Float %7.21%
Short Ratio1.35
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)0
Avg EPS beat(2)-3.79%
Min EPS beat(2)-6.22%
Max EPS beat(2)-1.36%
EPS beat(4)1
Avg EPS beat(4)-1.75%
Min EPS beat(4)-6.22%
Max EPS beat(4)2.56%
EPS beat(8)4
Avg EPS beat(8)2.8%
EPS beat(12)8
Avg EPS beat(12)7.86%
EPS beat(16)11
Avg EPS beat(16)6.89%
Revenue beat(2)0
Avg Revenue beat(2)-1.43%
Min Revenue beat(2)-1.6%
Max Revenue beat(2)-1.26%
Revenue beat(4)1
Avg Revenue beat(4)-0.25%
Min Revenue beat(4)-1.6%
Max Revenue beat(4)2.43%
Revenue beat(8)4
Avg Revenue beat(8)0.2%
Revenue beat(12)6
Avg Revenue beat(12)0.08%
Revenue beat(16)8
Avg Revenue beat(16)-0.03%
PT rev (1m)-10.85%
PT rev (3m)-13.8%
EPS NQ rev (1m)1.91%
EPS NQ rev (3m)2.56%
EPS NY rev (1m)0%
EPS NY rev (3m)-3.23%
Revenue NQ rev (1m)-0.07%
Revenue NQ rev (3m)0%
Revenue NY rev (1m)0%
Revenue NY rev (3m)-0.39%
Valuation
Industry RankSector Rank
PE 43.52
Fwd PE 33.15
P/S 9.42
P/FCF 44.7
P/OCF 39.16
P/B 3.41
P/tB 107.47
EV/EBITDA 97.99
EPS(TTM)0.54
EY2.3%
EPS(NY)0.71
Fwd EY3.02%
FCF(TTM)0.53
FCFY2.24%
OCF(TTM)0.6
OCFY2.55%
SpS2.49
BVpS6.9
TBVpS0.22
PEG (NY)1.39
PEG (5Y)N/A
Graham Number9.15
Profitability
Industry RankSector Rank
ROA -1.29%
ROE -1.93%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 67.29%
FCFM 21.07%
ROA(3y)10.38%
ROA(5y)5.42%
ROE(3y)11.36%
ROE(5y)5.39%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-1.8%
GM growth 5Y-1.83%
F-Score3
Asset Turnover0.24
Health
Industry RankSector Rank
Debt/Equity 0.4
Debt/FCF 5.34
Debt/EBITDA 10.46
Cap/Depr 25.48%
Cap/Sales 2.98%
Interest Coverage N/A
Cash Conversion 225.93%
Profit Quality N/A
Current Ratio 1.83
Quick Ratio 1.83
Altman-Z 4.5
F-Score3
WACC10.96%
ROIC/WACCN/A
Cap/Depr(3y)41.76%
Cap/Depr(5y)84.08%
Cap/Sales(3y)1.89%
Cap/Sales(5y)2.05%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)20%
EPS 3Y32.91%
EPS 5YN/A
EPS Q2Q%15.38%
EPS Next Y31.28%
EPS Next 2Y29.98%
EPS Next 3Y33.51%
EPS Next 5Y28.43%
Revenue 1Y (TTM)61.88%
Revenue growth 3Y34.08%
Revenue growth 5Y29.19%
Sales Q2Q%71.95%
Revenue Next Year29.41%
Revenue Next 2Y23.63%
Revenue Next 3Y21.57%
Revenue Next 5Y18.78%
EBIT growth 1Y-162.83%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year35.58%
EBIT Next 3Y27.09%
EBIT Next 5Y24.92%
FCF growth 1Y123.14%
FCF growth 3Y45.29%
FCF growth 5YN/A
OCF growth 1Y136.67%
OCF growth 3Y44.74%
OCF growth 5YN/A

CLEARWATER ANALYTICS HDS-A / CWAN FAQ

What is the ChartMill fundamental rating of CLEARWATER ANALYTICS HDS-A (CWAN) stock?

ChartMill assigns a fundamental rating of 4 / 10 to CWAN.


What is the valuation status for CWAN stock?

ChartMill assigns a valuation rating of 3 / 10 to CLEARWATER ANALYTICS HDS-A (CWAN). This can be considered as Overvalued.


What is the profitability of CWAN stock?

CLEARWATER ANALYTICS HDS-A (CWAN) has a profitability rating of 2 / 10.


Can you provide the financial health for CWAN stock?

The financial health rating of CLEARWATER ANALYTICS HDS-A (CWAN) is 4 / 10.